JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB261869

Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line

Be the first to review this product! Submit a review

|

(1 Publication)

SLC2A1 KO cell line available to order. KO validated by Next Generation Sequencing. Free of charge wild type control provided. Knockout achieved by CRISPR/Cas9 X = 1 bp insertion Frameshift = 100%.

View Alternative Names

CSE, Choreoathetosis/spasticity episodic (paroxysmal choreoathetosis/spasticity), DYT17, DYT18, DYT9, EIG12, Erythrocyte/hepatoma glucose transporter, GLUT, GLUT-1, GLUT1DS, GLUTB, GT1, GTG1, GTR1_HUMAN, Glucose transporter 1, Glucose transporter type 1, Glucose transporter type 1, erythrocyte/brain, Gtg3, HTLVR, HepG2 glucose transporter, Human T cell leukemia virus (I and II) receptor, MGC141895, MGC141896, PED, RATGTG1, Receptor for HTLV 1 and HTLV 2, Solute carrier family 2, Solute carrier family 2 (facilitated glucose transporter), member 1, Solute carrier family 2, facilitated glucose transporter member 1, erythrocyte/brain, facilitated glucose transporter member 1

3 Images
Next Generation Sequencing - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (AB261869)
  • NGS

Supplier Data

Next Generation Sequencing - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (AB261869)

1 bp insertion after Gln24 of the WT protein

Next Generation Sequencing - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (AB261869)
  • NGS

Lab

Next Generation Sequencing - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (AB261869)

X =1 bp insertion

Western blot - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (AB261869)
  • WB

Supplier Data

Western blot - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (AB261869)

All lanes:

Western blot - Anti-Glucose Transporter GLUT1 antibody [EPR3915] (<a href='/en-us/products/primary-antibodies/glucose-transporter-glut1-antibody-epr3915-ab115730'>ab115730</a>) at 1 µg/mL

Lane 1:

Wild-type A549 whole cell lysate at 20 µg

Lane 2:

Western blot - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (ab261869) at 20 µg

Lane 2:

Western blot - Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line (ab261869)

Predicted band size: 54 kDa

false

Key facts

Cell type

A549

Species or organism

Human

Tissue

Lung

Form

Liquid

form

Knockout validation

Next Generation Sequencing

Mutation description

Knockout achieved by CRISPR/Cas9 X = 1 bp insertion Frameshift = 100%

Disease

Carcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "NGS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Recommended control: Human wild-type A549 cell line (ab255450). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab261869-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab261869 Human SLC2A1 (Glucose Transporter GLUT1) knockout A549 cell line", "number":"AB261869-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SLC2A1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Next Generation Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
  • Do not allow the cell density to exceed 7x104 cells/cm2.
Culture medium

F-12K + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Glucose Transporter GLUT1 also known as SLC2A1 is an important protein responsible for the transport of glucose across cell membranes. The GLUT1 transporter has a molecular weight of approximately 55 kDa. This protein is highly expressed in erythrocytes endothelial cells lining blood vessels and in the blood-brain barrier. Its primary role is to facilitate the basal glucose uptake necessary for cellular metabolism particularly in tissues where glucose is a critical energy source.
Biological function summary

This glucose transporter plays a significant role in maintaining glucose homeostasis in the human body. GLUT1 functions independently and not as part of a complex. It ensures that glucose is available to cells with high metabolic demands including the brain and red blood cells where it remains important for survival and function. Its expression level can be influenced by various factors including hypoxia and insulin.

Pathways

GLUT1 is involved in the glycolysis and hypoxia-related pathways. It supports the glycolytic pathway by ensuring a sufficient supply of glucose to the cells which is then metabolized to produce ATP. Additionally during hypoxic conditions GLUT1 expression can increase aligning with proteins like HIF-1α which helps cells adapt by modifying their metabolism. This coordinated regulation permits cells to adjust their energy systems according to the oxygen availability.

GLUT1 is implicated in glucose transporter type 1 deficiency syndrome (GLUT1 DS) and various forms of cancer. GLUT1 DS results from inadequate glucose transport into the brain presenting neurological symptoms due to energy deficiency. In cancer overexpression of GLUT1 links to increased glucose uptake and tumor growth a condition known to involve proteins like hexokinase. These associations underline GLUT1's contribution to both genetic defects and metabolic shifts in cancerous tissues.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Open life sciences 18:20220697 PubMed37941780

2023

Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Shi,Litao Yu,Changhong Zhu,Haiyan Zhong
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com